DK1518930T3 - Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst - Google Patents

Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst

Info

Publication number: DK1518930T3
Authority: DK; Denmark
Prior art keywords: methods; compositions; cell growth; neoplastic cell; inhibiting neoplastic
Prior art date: 1998-10-13

Application number

DK04025897T

Other languages

Danish (da)

English (en)

Inventor

Avi Ashkenazi

Audrey Goddard

Austin L Gurney

Robert D Klein

Mary Napier

William I Wood

Jean Yuan

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-13

Filing date

1999-10-05

Publication date

2007-10-01

1999-10-05 Application filed by Genentech Inc filed Critical Genentech Inc

2007-10-01 Application granted granted Critical

2007-10-01 Publication of DK1518930T3 publication Critical patent/DK1518930T3/da

Links

238000000034 method Methods 0.000 title abstract 4
230000002401 inhibitory effect Effects 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
230000009826 neoplastic cell growth Effects 0.000 title abstract 2
230000000259 anti-tumor effect Effects 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000012010 growth Effects 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK04025897T 1998-10-13 1999-10-05 Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst DK1518930T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10408098P	1998-10-13	1998-10-13
PCT/US1999/023089 WO2000021996A2 (en)	1998-10-13	1999-10-05	Methods and compositions for inhibiting neoplastic cell growth

Publications (1)

Publication Number	Publication Date
DK1518930T3 true DK1518930T3 (da)	2007-10-01

Family

ID=22298575

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK99970398T DK1121439T3 (da)	1998-10-13	1999-10-05	Fremgangsmåder og præparater til inhibering af neoplastisk cellevækst
DK04025897T DK1518930T3 (da)	1998-10-13	1999-10-05	Fremgangsmåder og præparater til inhibering af neoplatisk cellevækst

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK99970398T DK1121439T3 (da)	1998-10-13	1999-10-05	Fremgangsmåder og præparater til inhibering af neoplastisk cellevækst

Country Status (15)

Country	Link
EP (1)	EP1121439B1 (de)
JP (1)	JP2002527452A (de)
KR (2)	KR100448426B1 (de)
AT (2)	ATE332970T1 (de)
AU (1)	AU758462B2 (de)
CA (1)	CA2344465A1 (de)
DE (2)	DE69932342T2 (de)
DK (2)	DK1121439T3 (de)
ES (2)	ES2268901T3 (de)
IL (3)	IL142088A0 (de)
MX (1)	MXPA01003636A (de)
NZ (1)	NZ510584A (de)
PT (2)	PT1518930E (de)
WO (1)	WO2000021996A2 (de)
ZA (1)	ZA200102380B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7169906B2 (en)	1997-09-17	2007-01-30	Genentech, Inc.	PRO211 polypeptides
US6974689B1 (en)	1997-09-18	2005-12-13	Genentech, Inc.	Nucleic acid encoding PRO211 polypeptides
CA2406855A1 (en) *	2000-04-21	2001-11-01	Takeda Chemical Industries, Ltd.	Novel insulin/igf/relaxin family polypeptides and dnas thereof
AU2008342942A1 (en) *	2007-12-28	2009-07-09	Biolnvent International Ab	Formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ226799A (en) *	1987-11-06	1991-08-27	Oncogen	Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) *	1989-04-10	1998-09-29	Bristol-Myers Squibb Company	Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) *	1990-04-03	1995-05-16	Bristol-Myers Squibb Company	Epithelins: novel cysteine-rich growth modulating proteins
WO1999014328A2 (en) *	1997-09-17	1999-03-25	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999014327A2 (en) *	1997-09-17	1999-03-25	Genentech, Inc.	Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer

1999
- 1999-10-05 JP JP2000575898A patent/JP2002527452A/ja active Pending
- 1999-10-05 DE DE69932342T patent/DE69932342T2/de not_active Expired - Lifetime
- 1999-10-05 AT AT99970398T patent/ATE332970T1/de active
- 1999-10-05 AT AT04025897T patent/ATE363536T1/de active
- 1999-10-05 PT PT04025897T patent/PT1518930E/pt unknown
- 1999-10-05 ES ES99970398T patent/ES2268901T3/es not_active Expired - Lifetime
- 1999-10-05 DE DE69936234T patent/DE69936234T2/de not_active Expired - Lifetime
- 1999-10-05 WO PCT/US1999/023089 patent/WO2000021996A2/en not_active Ceased
- 1999-10-05 EP EP99970398A patent/EP1121439B1/de not_active Expired - Lifetime
- 1999-10-05 NZ NZ510584A patent/NZ510584A/xx not_active IP Right Cessation
- 1999-10-05 KR KR10-2001-7004627A patent/KR100448426B1/ko not_active Expired - Fee Related
- 1999-10-05 PT PT99970398T patent/PT1121439E/pt unknown
- 1999-10-05 ES ES04025897T patent/ES2290606T3/es not_active Expired - Lifetime
- 1999-10-05 AU AU12005/00A patent/AU758462B2/en not_active Expired
- 1999-10-05 IL IL14208899A patent/IL142088A0/xx active IP Right Grant
- 1999-10-05 DK DK99970398T patent/DK1121439T3/da active
- 1999-10-05 CA CA002344465A patent/CA2344465A1/en not_active Abandoned
- 1999-10-05 DK DK04025897T patent/DK1518930T3/da active
- 1999-10-05 MX MXPA01003636A patent/MXPA01003636A/es active IP Right Grant
- 1999-10-05 KR KR10-2003-7014739A patent/KR100448427B1/ko not_active Expired - Fee Related
- 1999-10-05 ZA ZA200102380A patent/ZA200102380B/en unknown
2001
- 2001-03-19 IL IL142088A patent/IL142088A/en not_active IP Right Cessation
2008
- 2008-02-13 IL IL189502A patent/IL189502A0/en unknown

Also Published As

Publication number	Publication date
KR100448426B1 (ko)	2004-09-13
EP1121439B1 (de)	2006-07-12
ES2290606T3 (es)	2008-02-16
DE69932342T2 (de)	2007-07-12
PT1121439E (pt)	2006-12-29
AU758462B2 (en)	2003-03-20
DE69936234D1 (de)	2007-07-12
KR100448427B1 (ko)	2004-09-16
DK1121439T3 (da)	2006-11-13
IL142088A0 (en)	2002-03-10
IL142088A (en)	2008-11-26
WO2000021996A3 (en)	2000-11-09
KR20010085915A (ko)	2001-09-07
ATE363536T1 (de)	2007-06-15
WO2000021996A2 (en)	2000-04-20
CA2344465A1 (en)	2000-04-20
AU1200500A (en)	2000-05-01
KR20030096387A (ko)	2003-12-24
ZA200102380B (en)	2002-03-22
PT1518930E (pt)	2007-09-04
DE69936234T2 (de)	2008-03-06
DE69932342D1 (de)	2006-08-24
NZ510584A (en)	2003-04-29
ES2268901T3 (es)	2007-03-16
JP2002527452A (ja)	2002-08-27
MXPA01003636A (es)	2003-10-14
ATE332970T1 (de)	2006-08-15
EP1121439A2 (de)	2001-08-08
IL189502A0 (en)	2008-06-05

Publication	Publication Date	Title
WO2005023824A3 (en)	2005-06-09	Methods for inhibiting tumor cell proliferation
AP9901478A0 (en)	1999-03-31	Compounds for the treatment of ischemia.
AP2000001919A0 (en)	2000-09-30	Inhibitors of caspases.
ATE294595T1 (de)	2005-05-15	Radioaktive zusammensetzungen zur behandlung von prostatatumoren
NO20012152L (no)	2001-07-05	Materiale for hemming av proliferasjon av celler, og fremgangsmåte til fremstilling av samme, og anvendelse derav
WO2001075178A3 (en)	2002-06-06	Methods for identifying peptide aptamers capable of altering a cell phenotype
DE69918089D1 (de)	2004-07-22	Btk inhibitoren und verfahren zur identifizierung und verwendung
DK0768885T3 (da)	2004-12-06	Fremgangsmåde til inhibering af cancermetastase ved oral administration af oplöselig modificeret citruspectin
DK1202724T3 (da)	2004-01-26	Fremgangsmåde til behandling af kronisk smerte under anvendelse af mek-inhibitorer
EP1045851A4 (de)	2001-05-09	Substituierte porphyrinen
TR199900310T2 (xx)	1999-04-21	Trombin inhibit�rleri
DK1325011T3 (da)	2004-08-16	Fremgangsmåder og forbindelser til behandling af proliferative sygdomme
DE69913712T2 (de)	2004-10-07	Inhibitoren der bakteriellen nad synthetase
DK1017684T3 (da)	2003-03-03	Kontrastmiddel til afbildning af infarkter og nekroser
DK1383742T3 (da)	2011-02-14	Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
IL189502A0 (en)	2008-06-05	Methods and compositions for inhibiting neoplastic cell growth
DE69832363D1 (de)	2005-12-22	Betulinsauer Derivate zur Hemmung von Krebswachstum
ATE423129T1 (de)	2009-03-15	Inhibitoren von lyn-verbundener signaltransduktion (last) und deren verwendung zur behandlung von prostatakrebs
DK1143917T3 (da)	2004-06-01	Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
MXPA05001690A (es)	2005-10-19	Estrategia de deteccion para farmacos anticancer.
IL139144A0 (en)	2001-11-25	Mycobacterial inhibitors
DK0950056T3 (da)	2003-01-27	N-(pyridinylamino)isoindoliner og beslægtede forbindelser
EP1518930A3 (de)	2005-05-04	Verfahren und Zusammensetzung zur Hemmung des Wachsdums von neoplastischen Zellen
DE60312988D1 (de)	2007-05-16	Verwendung von einem chrysanthellum indicum extrakt zur behandlung der akne rosacea
MY117925A (en)	2004-08-30	Compounds for the inhibition of farnesyl protein transferase.